David Braun
@braunmdphd
Oncologist, physician-scientist @YaleCancer @YaleMed | cancer immunotherapy, genomics, kidney cancer | tweets ≠ medical advice. ASCO FCOI:bit.ly/3Sv8P6A
ID: 990313941149548544
https://www.thebraunlab.org/ 28-04-2018 19:36:57
1,1K Tweet
3,3K Followers
1,1K Following
Thank you Katy Beckermann for the wonderful discussion! Yale Cancer Center Yale School of Medicine Yale Pathology Yale Urology
Happy to share that our work that identified a new driver of brain metastasis is out in Science Advances medicine.yale.edu/pathology/news… The manuscript is here: science.org/doi/10.1126/sc…
Thank you so much American College of Cardiology ! This is all due to all my amazing mentors 🙏and colleagues! ❤️I am excited for all the work ahead! Marcelo Di Carli Ron Blankstein Kat Liao Joseph Merola, MD MMSc Monica Mukherjee MD, MPH OMRF Penn IGG #JoelKatz Brigham and Women’s Cardiovascular Imaging Program AntonioAbbate Dr. Michael Garshick
Congratulations to Matthew Meyerson, MD, PhD, FAACR, Toni Choueiri, MD, and Alice T. Shaw, MD, PhD, recipients of AACR 2025 Scientific Achievement Awards. Dana-Farber Read more here: bit.ly/4j7m8om
All patients who received a personalized #vaccine for advanced #kidneycancer achieved an immune response, according to results of a phase 1 trial. Healio spoke with David Braun of Yale School of Medicine and Yale Cancer Center about the data and its implications. 🔗Read here bit.ly/3QJDSd6
In a recent study, YSM researchers at Yale Cancer Center including David Braun identify #immune system features they say could be targeted to improve care for treatment #resistant #cancers: brnw.ch/21wS0vI
🎉CONGRATULATIONS to Tom Mitchell, recipient of the KCA's 2025 Christopher G. Wood Rising Star Award recognizing talented emerging #kidneycancer experts! The award will be presented at #IKCSEU25, don't miss his lecture followed by WoodFire 🔥! kidneycancer.swoogo.com/IKCSEU25
Review led by superstar heme/onc fellow Zak Yochum Yale Hematology Oncology Fellows
Great review in Cancer Cell on the impact, challenges and opportunities of AI in translational cancer research from Josephine Yates and Eli Van Allen sciencedirect.com/science/articl…
Trying to keep up with all the recent @kidneycancer biomarker developments? Check out our new review for all the latest updates. Brian Rini, MD Vanderbilt University Medical Center pubmed.ncbi.nlm.nih.gov/40240621/
Groundbreaking work on teaching LLMs the language of biology, from David van Dijk Yale School of Medicine
🌟Such a smart and forward-looking presentation by David Braun on RCC immunobiology and neoantigen strategies at #IKCSEU25! Kidney Cancer OncoAlert 🟠 Understanding RCC immune evasion remains a key challenge 🟠 ZNF683+ SLAMF7+ exhausted CD8+ T cells linked to anti-PD-1
Happy to share the team latest investigation of BIONIK trial showing unexpectedly that angiogenic signature is associated with response to immunotherapy in ccRCC, against the current dogma! @igbmc thanks to Stéphane Oudard nature.com/articles/s4169…
The topic was “Translational Studies to Define the Determinants of Anti-Tumor Immunity in Kidney Cancer” at today’s Yale Cancer Center Translational Science Retreat as David Braun took to the podium. Dr. Braun is an Assistant Professor of Medicine Yale School of Medicine
From the May issue: 'Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in RCC brnw.ch/21wSSDz By Miya Hugaboom, Lena Wirth, Kelly Street, Neil Ruthen, Michael Atkins, Catherine Wu, David Braun
